Latest / Research To Practice | Oncology Videos
Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Wojciech Jurczak MD, PhD
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Faculty Presentation 1: Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Newly Diagnosed and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) — Wojciech Jurczak MD, PhD
CME information and select publications
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.